Clinical Trials Logo

Clinical Trial Summary

The prospective observational study delves into the complex relationship between neuroinflammation and oxidative stress in post-cardiac surgery complications, focusing on postoperative cognitive dysfunction.


Clinical Trial Description

The prospective observational study meticulously examines the interplay between neuroinflammation and oxidative stress in the realm of post-cardiac surgery complications, specifically targeting postoperative cognitive dysfunction. Its primary objective is to comprehensively assess the sustained influence of these intricate processes on cognitive function and overall well-being, extending beyond the immediate aftermath of surgery. The research endeavors to probe deeply into the molecular mechanisms and clinical ramifications associated with neuroinflammation and oxidative stress, centering on their pivotal role in shaping the onset and trajectory of postoperative cognitive dysfunction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06391866
Study type Observational [Patient Registry]
Source Europainclinics z.ú.
Contact Ladislav Kocan, MD, PhD, FIPP
Phone +421557891110
Email europainclinicsstudy@gmail.com
Status Recruiting
Phase
Start date April 30, 2024
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT03100136 - Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer Phase 1
Not yet recruiting NCT05129514 - Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery N/A
Recruiting NCT04318626 - The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment Phase 2
Enrolling by invitation NCT05350774 - Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 Phase 2
Completed NCT03058328 - The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.
Withdrawn NCT04423471 - Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
Recruiting NCT04814355 - The Effect of Celecoxib on Neuroinflammation in MDD Phase 4